Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
GE Healthcare Launches Cytell™ Cell Imaging System
Wednesday, June 25, 2014
Streamlines data acquisition, analysis and visualization.

Consistent & Efficient Purification of NGS Library Reactions
Tuesday, June 24, 2014
MagSi-NGSPREP offers an efficient solution for DNA clean-up and size selection.

Molecular Devices to attend 9th FENS Forum of Neuroscience 2014
Tuesday, June 24, 2014
Company will be showcasing its range of Axon Instruments at FENS 2014 (Hall 4, Booth 146) in Milan from 5 July 2014.

Tecan Unveils Fluent™ Laboratory Automation Solutions
Tuesday, June 24, 2014
Tecan has introduced the Fluent™ laboratory automation solution, the latest addition to its world-class laboratory automation portfolio.

Leti and Akrivis Develop Nanomedicine Platform for High Payload Targeted Drug Delivery
Saturday, June 21, 2014
New theranostic platform will combine ultrasensitive detection, high payloads and more efficient cell targeting.

New Webinar on Improving Process Development Timelines with Mini Bioreactors
Saturday, June 21, 2014
Details fermentation and bioprocessing data generated by ambr250.

Agilent Introduces Novel Synthetic Biology System
Saturday, June 21, 2014
QuikChange HT system accelerates protein engineering.

Hudson Robotics Announces the Release of New White Paper
Friday, June 20, 2014
Company’s new research reveals optimal settings for multi-channel pipettors.

Diamond Light Source Purchases Multiple Electron Microscopes from FEI
Thursday, June 19, 2014
The U.K.’s national synchrotron now has a complete cryo-EM workflow for integrative structural biology to explore essential biological questions at the atomic and molecular scale.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 2587
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv